百富環球(00327)以4,360萬人幣悉數出售芯片業務股權
百富環球(00327.HK)公佈,附屬萬達百匯以約4,360萬元人民幣(下同),向第三方買方出售其於兆訊恆達的全部3.64%股權。出售事項完成後,萬達百匯將不再擁有兆訊恆達任何股權。
另外,萬達百匯收到兆訊香港就兆訊香港擬以總代價約2.087億元,向承讓人轉讓兆訊恆達合共約20%股權發出的轉讓通知。董事會批準萬達百匯不行使優先購買權。
萬達百匯於2019年與其他訂約方訂立投資協議,萬達百匯於管理層股東悉數行使兆訊恆達購股權計劃項下兆訊恆達購股權後,認購兆訊恆達之註冊資本,代價爲2,000萬元。
兆訊恆達爲百富環球主要股東高陽科技(00818.HK)的間接全資附屬公司。其主要業務活動包括銷售信息安全芯片及解決方案、電腦硬件及軟件、系統集成及芯片系統開發。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.